Portosystemic shunt is an effective treatment for complications of portal hypertension in hepatic myeloid metaplasia and improves nutritional status.

Autor: Aspite, Silvia1 (AUTHOR), Schepis, Filippo2 (AUTHOR), Roccarina, Davide1 (AUTHOR), Gitto, Stefano1 (AUTHOR), Citone, Michele3 (AUTHOR), Di Bonaventura, Chiara1 (AUTHOR), Bianchini, Marcello2 (AUTHOR), Arena, Umberto1 (AUTHOR), Vannucchi, Alessandro M.1,4,5 (AUTHOR), Guglielmelli, Paola1,4,5 (AUTHOR), Campani, Francesca6 (AUTHOR), Fanelli, Fabrizio3 (AUTHOR), Marra, Fabio1,5 (AUTHOR), Vizzutti, Francesco1 (AUTHOR) francesco.vizzutti@unifi.it
Zdroj: Liver International. Feb2022, Vol. 42 Issue 2, p419-424. 6p. 1 Color Photograph, 1 Chart, 1 Graph.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje